The insulin sensitivity response is determined by the interaction between the G972R polymorphism of the insulin receptor substrate 1 gene and dietary fat

Molecular Nutrition and Food Research

Volumn 55, Issue 2, 2011, Pages 328-335

  Marín, Carmen ^a   Pérez Martínez, Pablo ^a   Delgado Lista, Javier ^a   Gómez, Purificación ^a   Rodríguez, Fernando ^a   Yubero Serrano, Elena María ^a   García Ríos, Antonio ^a   Camargo, Antonio ^a   Pérez Jiménez, Francisco ^a   López Miranda, José ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Carbohydrates; Dietary fat; Insulin receptor substrate 1 G972R polymorphism; Insulin sensitivity; Intervention study

Indexed keywords

CHOLESTEROL; FATTY ACID; INSULIN RECEPTOR SUBSTRATE; IRS1 PROTEIN, HUMAN; LIPOPROTEIN; LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID;

ADULT; ARTICLE; BLOOD; BODY MASS; CARBOHYDRATE DIET; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FAT INTAKE; FEMALE; GENETIC ASSOCIATION; GENETICS; GLUCOSE BLOOD LEVEL; HETEROZYGOTE; HUMAN; INSULIN RESISTANCE; LOW FAT DIET; MALE; RANDOMIZED CONTROLLED TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL; CROSS-OVER STUDIES; DIET, FAT-RESTRICTED; DIETARY CARBOHYDRATES; DIETARY FATS; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, NONESTERIFIED; FEMALE; GENETIC ASSOCIATION STUDIES; HETEROZYGOTE; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; LIPOPROTEINS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SPAIN; YOUNG ADULT;

EID: 79551526797     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201000235     Document Type: Article

References (39)

1. Weyer, C., Bogardus, C., Mott, D. M., Pratley, R. E., The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J. Clin. Invest. 1999, 104, 787-794.
2. Bergman, R. N., Zaccaro, D. J., Watanabe, R. M., Haffner, S. M., et al., Minimal model-based insulin sensitivity has greater heritability and a different genetic basis than homeostasis model assessment or fasting insulin. Diabetes 2003, 52, 2168-2174.
3. Pérez-Martínez, P., López-Miranda, J., Cruz-Teno, C., Delgado-Lista, J., et al., Adiponectin gene variants are associated with insulin sensitivity in response to dietary fat consumption in Caucasian men. J. Nutr. 2008, 138, 1609-1614.
4. Marín, C., Pérez-Jiménez, F., Gómez, P., Delgado, J., et al., The Ala54Thr polymorphism of the fatty acid-binding protein 2 gene is associated with a change in insulin sensitivity after a change in the type of dietary fat. Am. J. Clin. Nutr. 2005, 82, 196-200
5. Mayer-Davis, E. J., Monaco, J. H., Hoen, H. M., Carmichael, S., et al., Dietary fat and insulin sensitivity in a triethnic population: the role of obesity. The IR Atherosclerosis Study (IRAS). Am. J. Clin. Nutr. 1997, 67, 79-87.
6. Risérus, U., Fatty acids and insulin sensitivity. Curr. Opin. Clin. Nutr. Metab. Care 2008, 11, 100-105.
7. Perez-Jimenez, F., Lopez-Miranda, J., Pinillos, M. D., Gomez, P., et al., A Mediterranean and a high-carbohydrate diet improve glucose metabolism in healthy young persons. Diabetologia 2001, 44, 2038-2043.
8. Storlien, L. H., Pan, D. A., Kriketos, A. D., Baur, L. A., High fat diet-induced IR. Lessons and implications from animal studies. Ann. N. Y. Acad. Sci. 1993, 683, 82-90.
9. Gao, Z., Zhang, X., Zuberi, A., Hwang, D., et al., Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes. Mol. Endocrinol. 2004, 18, 2024-2034.
10. Richard, J., Wood and Maria Luz Fernandez. Carbohydrate-restricted versus low-glycemic-index diets for the treatment of insulin resistance and metabolic syndrome. Nutr. Rev. 2009, 67, 179-183.
11. Kusari, J., Verma, U. S., Buse, J. B., Analysis of the gene sequences of the insulin receptor and the insulin-sensitive glucose transporter (GLU-4) in patients with common type non-insulin-dependent diabetes mellitus. J. Clin. Invest. 1991, 88, 1323-1330.
12. Almind, K., Bjorbaek, C., Vestergaard, H., Hansen, T., et al., Aminoacid polymorphism of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet 1993, 342, 828-832.
13. Prudente, S., Morini, E., Trischitta, V., Insulin signaling regulating genes: effect on T2DM and cardiovascular risk. Nat. Rev. Endocrinol. 2009, 5, 682-693.
14. Clausen, J. O., Hansen, T., Bjørbaek, C., Echwald, S. M., et al., Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1. Lancet 1995, 346, 397-402.
15. Baroni, M. G., D'Andrea, M. P., Montali, A., Pannitteri, G., et al., A common mutation of the insulin receptor substrate-1 gene is a risk factor for coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 1999, 19, 2975-2980.
16. Baroni, M. G., Leonetti, F., Sentinelli, F., Romeo, S., et al., The G972R variant of the insulin receptor substrate-1 (IRS-1) gene is associated with IR in "uncomplicated" obese subjects evaluated by hyperinsulinemic-euglycemic clamp. J. Endocrinol. Invest. 2004, 27, 754-759.
17. Almind, K., Inoue, G., Pedersen, O., Kahn, C. R., A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection Studies. J. Clin. Invest. 1996, 97, 2569-2575.
18. Sentinelli, F., Filippi, E., Cavallo, M. G., Romeo, S., et al., The G972R variant of the insulin receptor substrate-1 gene impairs insulin signalling and cell differentiation in 3T3L1 adipocytes; treatment with a PPARgamma agonist restores normal cell signalling and differentiation. J. Endocrinol. 2006, 188, 271-285.
19. Federici, M., Pandolfi, A., De Filippis, E. A., Pellegrini, G., et al., G972R IRS-1 variant impairs insulin regulation of endothelial nitric oxide synthase in cultured human endothelial cells. Circulation 2004, 109, 399-405.
20. Jellema, A., Zeegers, M. P., Feskens, E. J., Dagnelie, P. C., Mensink, R. P., Gly972Arg variant in the insulin receptor substrate-1 gene and association with Type 2 diabetes: a meta-analysis of 27 studies. Diabetologia 2003, 46, 990-995.
21. National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third report of the national cholesterol education program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation, 2002, 106, 3143-3421.
22. Association of Official Analytical Chemists. Official methods of analysis of the A. O. A. C. 15th ed. Arlington, VA 1990 (S585.A8).
23. Ruiz-Gutiérrez, V., Prada, J. L., Pérez Jiménez, F., Determination of fatty acid and triacylglycerol composition of human very low density lipoproteins. J. Chromatogr. 1993, 662, 117-134.
24. Allain, C. C., Poon, L. S., Chang, C. S. G., Richmond, W., Fu, P. C., Enzymatic determination of total serum cholesterol. Clin. Chem. 1974, 20, 470-475.
25. Bucolo, G., David, H., Quantitative determination of serum triacilglycerols by use of enzymes. Clin. Chem. 1973, 19, 476-482.
26. Warnick, G. R., Benderson, J., Alberts, J. J., Dextran sulfate-Mg precipitation procedure of quantitation of high density lipoprotein cholesterol. Clin. Chem. 1982, 28, 1379-1388.
27. Friedelwald, W. T., Levy, R. I., Fredrickson, D. S., Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin. Chem. 1972, 98, 499-502.
28. Shimizu, S., Inoue, K., Tani, Y., Yamada, H., Enzymatic microdetermination of serum free fatty acids. Anal. Biochem. 1979, 98, 341-345.
29. Harano, Y., Hidaka, H., Takatsuki, K., Ohgaku, S., et al., Glucose, insulin, and somatostatin infusion for the determination of insulin sensitivity in vivo. Metabolism 1978, 27, 1449-1452.
30. Laws, A., Jeppesen, J. L., Maheux, P. C., Schaal, P., et al., Resistance to insulin stimulated glucose uptake and dyslipidemia in Asian Indians. Arterioscler. Thromb. 1994, 14, 917-922.
31. Funda, E., Orkunoglu, S., Hatice, M., Erol, B., Metin, O., Molecular Scanning formutations in the insulin receptor substrate-1 (IRS-1) gene in Turkish with 2 Diabetes Mellitus. Endocrine J. 2005, 52, 593-598
32. Frangioudakis, G., Ye, J. M., Cooney, G. J., Both saturated and n-6 polyunsaturated fat diets reduce phosphorylation of insulin receptor substrate-1 and protein kinase B in muscle during the initial stages of in vivo insulin stimulation. Endocrinology 2005, 146, 5596-5603.
33. Purnell, J. Q., Brunzell, J. D., The central role of dietary fat, not carbohydrate, in the insulin resistance syndrome. Curr. Opin. Lipidol. 1997, 8, 17-22.
34. Marini, M. A., Frontoni, S., Mineo, D., Bracaglia, D., et al., The Arg972 variant in insulin receptor substrate-1 is associated with an atherogenic profile in offspring of type 2 diabetic patients. J. Clin. Endocrinol. Metab. 2003, 8, 3368-3371.
35. Farese, R. V., Insulin-sensitive phospholipid signaling systems and glucose transport. Update II. Exp. Biol. Med. 2001, 226, 283-295.
36. Okada, T., Kawano, Y., Sakakibara, T., Hazeki, O., et al., Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J. Biol. Chem. 1994, 269, 3568-3573.
37. Yu, C., Chen, Y., Cline, G. W., Zhang, D., et al., Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 2002, 277, 50230-50236.
38. Bederman, I. R., Previs, S. F., Hormonal regulation of intracellular lipolysis in C57BL/6J mice: effect of diet-induced adiposity and data normalization. Metabolism 2008, 57, 1405-1413.
39. Dresner, A., Laurent, D., Marcucci, M., Griffin, M. E., et al., Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J. Clin. Invest. 1999, 103, 253-259.